Use of purpurogallin and glycosides thereof in treating ischemia

Details Use of purpurogallin and glycosides thereof in treating ischemia Use of purpurogallin and glycosides thereof in treating ischemia

1992-09-28

1993-09-28

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 42, 514681, A61C 3170, A61C 3112

Patent

active

052486680

ABSTRACT:
Purpurogallin and its mono- and di-glucosides are useful as cytoprotective agents. Patient-administrable compositions for addition to a patient's blood to minimize oxyradical damage caused by ischemia-reperfusion injury that may result in various surgical procedures, and comprising purpurogallin or glucosides thereof, and uses thereof, are described.

REFERENCES:
patent: 4181545 (1990-01-01), Anderson
patent: 4647532 (1987-03-01), Watanabe
Chem Abst. 111(3):17704v of Jordan, PCT Int. Appl. WO 8803805 Jun. 2, 1988 Abstract only.
Merck Index, 11th Edition, entry No. 7963 1989.
Free Radical Research Communications, vol. 2, Nos. 1-2, 1986, Kontoghiorghes.
"Natural Immunity and Cell Growth Regulation", vol. 4, No. 5, Sep.-Oct. 1985 Leung.

Affiliated with

Also associated with

Rating

Use of purpurogallin and glycosides thereof in treating ischemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of purpurogallin and glycosides thereof in treating ischemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of purpurogallin and glycosides thereof in treating ischemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2190957